Increase in antibody-dependent cellular cytotoxicity (ADCC) in a patient with advanced colorectal carcinoma carrying a KRAS mutation under lenalidomide therapy.
Cancer Biol Ther
; 15(3): 266-70, 2014 Mar 01.
Article
in En
| MEDLINE
| ID: mdl-24351336
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thalidomide
/
Colorectal Neoplasms
/
Proto-Oncogene Proteins
/
Adenomatous Polyposis Coli
/
Ras Proteins
/
Angiogenesis Inhibitors
/
Antibody-Dependent Cell Cytotoxicity
Limits:
Adult
/
Female
/
Humans
Language:
En
Journal:
Cancer Biol Ther
Journal subject:
NEOPLASIAS
/
TERAPEUTICA
Year:
2014
Document type:
Article
Affiliation country:
Country of publication: